Literature DB >> 9624761

Is there sufficient evidence for us to encourage the widespread use of hormone replacement therapy to prevent disease?

P C Hannaford.   

Abstract

Mesh：

Year:  1998        PMID： 9624761      PMCID： PMC1409993     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  9 in total

Review 1.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

2.  Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials.

Authors:  E Hemminki; K McPherson
Journal:  BMJ       Date:  1997-07-19

3.  Prior to use of estrogen replacement therapy, are users healthier than nonusers?

Authors:  K A Matthews; L H Kuller; R R Wing; E N Meilahn; P Plantinga
Journal:  Am J Epidemiol       Date:  1996-05-15       Impact factor: 4.897

4.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

Authors:  F Grodstein; M J Stampfer; J E Manson; G A Colditz; W C Willett; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

5.  The epidemiology of hysterectomy: findings in a large cohort study.

Authors:  M P Vessey; L Villard-Mackintosh; K McPherson; A Coulter; D Yeates
Journal:  Br J Obstet Gynaecol       Date:  1992-05

6.  Prevalence and characteristics associated with use of hormone replacement therapy in Britain.

Authors:  T Moorhead; P Hannaford; M Warskyj
Journal:  Br J Obstet Gynaecol       Date:  1997-03

7.  Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records.

Authors:  T Lancaster; G Surman; M Lawrence; D Mant; M Vessey; M Thorogood; P Yudkin; E Daly
Journal:  J Epidemiol Community Health       Date:  1995-08       Impact factor: 3.710

8.  The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement.

Authors:  M Falkeborn; I Persson; H O Adami; R Bergström; E Eaker; H Lithell; R Mohsen; T Naessén
Journal:  Br J Obstet Gynaecol       Date:  1992-10

9.  The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.

Authors:  B M Psaty; S R Heckbert; D Atkins; R Lemaitre; T D Koepsell; P W Wahl; D S Siscovick; E H Wagner
Journal:  Arch Intern Med       Date:  1994-06-27
  9 in total
  1 in total

1.  Hormone replacement therapy.

Authors:  H Winpenny
Journal:  Br J Gen Pract       Date:  1998-05       Impact factor: 5.386
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.